Dr. Tony Ning, MD (he/him) is a Rheumatologist, Internist in Durham, NC with over 17 years of experience. What is your opinion of Dr. Tony Ning, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Tony Ning, MD has received over $59,650 which includes payments from the following companies:
$50,879.61 from AbbVie, Inc.
$2,571.04 from Pfizer Inc.
$2,107.89 from Celgene Corporation
$965.40 from Amgen Inc.
$610.83 from Genentech USA, Inc.
$521.67 from E.R. Squibb & Sons, L.L.C.
$323.96 from Janssen Biotech, Inc.
$251.58 from UCB, Inc.
$228.61 from Mallinckrodt LLC
$185.85 from Horizon Pharma plc
$174.85 from Novartis Pharmaceuticals Corporation
$168.30 from Iroko Pharmaceuticals, LLC
$147.65 from Questcor Pharmaceuticals
$125.42 from Takeda Pharmaceuticals America, Inc.
$120.09 from GlaxoSmithKline, LLC.
$82.94 from LILLY USA, LLC
$64.51 from MEDAC PHARMA, INC.
$29.46 from West-Ward Pharmaceuticals
$19.66 from Regeneron Healthcare Solutions, Inc.
$14.72 from Ferring Pharmaceuticals Inc.
Payments received by Dr. Tony Ning, MD were from the following categories:
$44,775.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!